KLAS Contact
Contact KLAS
Contact KLAS
2025 BEST IN KLAS
Preferences
Related Series
2022
2017
2016
Related Segments
Patient Communications 2025
How Well Are Vendors Delivering Capabilities That Drive Meaningful Patient Interactions?
Author
Adam Cherrington
Author
Spencer Snyder
Patient communications solutions are critical to assisting patients in their healthcare journey, helping to ensure effective data exchange, timely care, and improved patient health outcomes. As healthcare organizations face continued pressure to increase patients’ access to care while also reducing the staff burden, many are looking to communications solutions for aid, and KLAS’ Patient Engagement 2025 report shows that these tools are the second highest investment priority among patient engagement technology. To aid organizations as they search for broad platforms that support meaningful patient interactions, this report shares customer experiences and outcomes with patient communications vendors as well as other market trends.
If you don't have a login, getting started is easy.
Key Findings:
- Epic Clients Highlight Integrated Platform, Note Some Functionality Gaps; Relatient & TeleVox Showing Improvement but Innovation & Usability Remain Works in Progress
- RevSpring & CipherHealth Seen as Long-Term Partners; Customers of Both Want More Consistent, Proactive Support
- Artera, Luma Health & Upfront Offer Reliable, Customizable Products; Customers Seek Improved Value
- Early Insights Show Luma Health*, Artera* & TeleVox* Offer Mature & Dynamic Texting Functionality
*Limited data
Writer
Natalie Hopkins
Designer
Nikki Christensen
Project Manager
Andrew Wright
This material is copyrighted. Any organization gaining unauthorized access to this report will be liable to compensate KLAS for the full retail price. Please see the KLAS DATA USE POLICY for information regarding use of this report. © 2025 KLAS Research, LLC. All Rights Reserved. NOTE: Performance scores may change significantly when including newly interviewed provider organizations, especially when added to a smaller sample size like in emerging markets with a small number of live clients. The findings presented are not meant to be conclusive data for an entire client base.